CoreCap Advisors’s Zomedica Corp. ZOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $384 | Hold |
4,800
| – | – | ﹤0.01% | 2857 |
|
|
2026
Q2 | $480 | Hold |
4,800
| – | – | ﹤0.01% | 2867 |
|
|
2026
Q1 | $573 | Hold |
4,800
| – | – | ﹤0.01% | 2630 |
|
|
2025
Q4 | $488 | Hold |
4,800
| – | – | ﹤0.01% | 2709 |
|
|
2025
Q3 | $379 | Hold |
4,800
| – | – | ﹤0.01% | 2606 |
|
|
2025
Q2 | $194 | Buy |
+4,800
| New | +$194 | ﹤0.01% | 2624 |
|
|
2025
Q1 | – | Sell |
-7,513
| Closed | -$902 | – | 3349 |
|
|
2024
Q4 | $902 | Hold |
7,513
| – | – | ﹤0.01% | 2394 |
|
|
2024
Q3 | $1.03K | Sell |
7,513
-10,000
| -57% | -$1.4K | ﹤0.01% | 2270 |
|
|
2024
Q2 | $2.56K | Hold |
17,513
| – | – | ﹤0.01% | 1276 |
|
|
2024
Q1 | $2.56K | Hold |
17,513
| – | – | ﹤0.01% | 2071 |
|
|
2023
Q4 | $3.51K | Hold |
17,513
| – | – | ﹤0.01% | 603 |
|
|
2023
Q3 | $2.93K | Sell |
17,513
-20,000
| -53% | -$3.88K | ﹤0.01% | 551 |
|
|
2023
Q2 | $7.5K | Buy |
+37,513
| New | +$7.61K | ﹤0.01% | 573 |
|
|
2022
Q4 | $8.56K | Hold |
52,513
| – | – | ﹤0.01% | 1590 |
|
|
2022
Q3 | $11K | Sell |
52,513
-27,330
| -34% | -$7.23K | ﹤0.01% | 540 |
|
|
2022
Q2 | $18K | Hold |
79,843
| – | – | ﹤0.01% | 1293 |
|
|
2022
Q1 | $27K | Sell |
79,843
-3,600
| -4% | -$1.18K | ﹤0.01% | 546 |
|
|
2021
Q4 | $26K | Buy |
+83,443
| New | +$37.6K | ﹤0.01% | 1237 |
|
CoreCap Advisors's ZOM Position: Q3 2026 in Review
CoreCap Advisors held its Zomedica Corp. (ZOM) position steady in Q3 2026 at 4,800 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #2857.
CoreCap Advisors first reported a position in ZOM in Q4 2021 and has held it in 18 quarters since. The position peaked at $27K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZOM as of Q3 2026.
- CoreCap Advisors held 4,800 shares of Zomedica Corp. worth $384 as of Q3 2026.
- CoreCap Advisors left its Zomedica Corp. share count unchanged in Q3 2026.
- Zomedica Corp. made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2857 holding.
- CoreCap Advisors first reported a position in Zomedica Corp. in Q4 2021 and has held it in 18 quarters since.
- CoreCap Advisors's Zomedica Corp. position peaked at $27K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Zomedica Corp. as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.